Exane Derivatives’s Toyota TM Stock Holding History

Exane Derivatives’s Portfolio TM Stock Details TM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10	Closed	-$4.05K	–	864
2020 Q3	$4.05K	Buy	+10	New	+$1.3K	﹤0.01%	522

Other funds holding TM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SRB Corp Boston, Massachusetts $1.63B AUM 20.77% 1-Year Est. Return

CCM

Cullen Capital Management New York $9.75B AUM 21.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Exane Derivatives's TM Position: Q2 2022 in Review

Exane Derivatives sold out of Toyota (TM) in Q2 2022, closing a stake of 210 shares — an estimated $37.9K sold.

Exane Derivatives first reported a position in TM in Q3 2016 and held it in 12 quarters. The position peaked at $161K in Q1 2017. 445 funds tracked by Wall St. Rank hold TM as of Q2 2022.

Exane Derivatives reported no remaining Toyota position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 210 Toyota shares in Q2 2022, an estimated $37.9K.
Exane Derivatives first reported a position in Toyota in Q3 2016 and held it in 12 quarters.
Exane Derivatives's Toyota position peaked at $161K in Q1 2017.
445 funds tracked by Wall St. Rank held Toyota as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.